{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:27:39Z","timestamp":1776299259358,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Taiho Pharmaceutical Co., Tokyo, Japan"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.anl.2016.07.021","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T08:12:26Z","timestamp":1472026346000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial"],"prefix":"10.1016","volume":"44","author":[{"given":"Kimihiro","family":"Okubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1229-3261","authenticated-orcid":false,"given":"Michinori","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2016.07.021_bib0060","series-title":"WAO white book on allergy 2013 update","first-page":"27","author":"Pawankar","year":"2013"},{"key":"10.1016\/j.anl.2016.07.021_bib0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2332\/allergolint.14-RAI-0768","article-title":"Japanese guideline for allergic rhinitis 2014","volume":"63","author":"Okubo","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2016.07.021_bib0070","first-page":"S1","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2016.07.021_bib0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anl.2011.12.006","article-title":"Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline","volume":"39","author":"Fujieda","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2016.07.021_bib0080","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2165\/00003495-200666180-00004","article-title":"Selecting the oral antihistamine for patients with allergic rhinitis","volume":"66","author":"Lehman","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.anl.2016.07.021_bib0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14740338.1.3.225","article-title":"Emerging safety issues regarding long-term usage of H1-receptor antagonists","volume":"1","author":"Walsh","year":"2002","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.anl.2016.07.021_bib0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2012.672405","article-title":"Safety considerations in the management of allergic diseases: focus on antihistamines","volume":"28","author":"Yanai","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anl.2016.07.021_bib0095","unstructured":"Ilaxten 20 mg tablets. Bilastine 20 mg. Summary of product characteristics. Available from: http:\/\/www.mhra.gov.uk\/spc-pil\/?prodName=ILAXTEN20MG TABLETS&subsName=&pageID=ThirdLevel&searchTerm=bilastine#retainDisplay [accessed 27.11.15]."},{"key":"10.1016\/j.anl.2016.07.021_bib0100","article-title":"Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study","author":"Okubo","year":"2016","journal-title":"Allegol Int"},{"key":"10.1016\/j.anl.2016.07.021_bib0105","series-title":"ICH Harmonised Tripartite Guideline: the extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions","author":"ICH Steering Committee","year":"1994"},{"key":"10.1016\/j.anl.2016.07.021_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1185\/03007995.2011.640667","article-title":"Efficacy and safety of bilastine 20mg compared with cetirizine 10mg and placebo in the treatment of perennial allergic rhinitis","volume":"28","author":"Sastre","year":"2012","journal-title":"Curr Med Res Opin"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814616302358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814616302358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:32:24Z","timestamp":1759951944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814616302358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0385814616302358"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2016.07.021","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2016.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}